APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

VLP Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global VLP Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17404716032 January 2026190 pages

Choose your research edition.

Industry ResearchVLP Vaccines Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal VLP Vaccines Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal VLP Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal VLP Vaccines Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal VLP Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global VLP Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of VLP Vaccines include H&Z Life Science, Merck, Gproan, VLP Therapeutics, VBI, Spybiotech, Saiba Animal Health, POSVAX and Optipharm Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global VLP Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of VLP Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents VLP Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the VLP Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

VLP Vaccines Segment by Company

H&Z Life Science

Merck

Gproan

VLP Therapeutics

VBI

Spybiotech

Saiba Animal Health

POSVAX

Optipharm Co. Ltd

Novavax

Medicago

ARTES Biotechnology

VLP Vaccines Segment by Type

Hepatitis B Vaccine

Covid-19 Vaccine

HPV Vaccine

Others

VLP Vaccines Segment by Application

Government

Medical Institution

Others

VLP Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global VLP Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of VLP Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of VLP Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the VLP Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of VLP Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of VLP Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of VLP Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. VLP Vaccines Industry Trends Table 2. VLP Vaccines Industry Drivers Table 3. VLP Vaccines Industry Opportunities and Challenges Table 4. VLP Vaccines Industry Restraints Table 5. Global VLP Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global VLP Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global VLP Vaccines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global VLP Vaccines Sales Market Share by Manufacturers Table 9. Global VLP Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global VLP Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global VLP Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global VLP Vaccines Manufacturers, Product Type & Application Table 13. Global VLP Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global VLP Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hepatitis B Vaccine Table 17. Major Manufacturers of Covid-19 Vaccine Table 18. Major Manufacturers of HPV Vaccine Table 19. Major Manufacturers of Others Table 20. Global VLP Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 22. Global VLP Vaccines Sales by Type (2027-2032) & (K Units) Table 23. Global VLP Vaccines Sales Market Share by Type (2021-2026) Table 24. Global VLP Vaccines Sales Market Share by Type (2027-2032) Table 25. Global VLP Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global VLP Vaccines Revenue by Type (2021-2026) & (K Units) Table 27. Global VLP Vaccines Revenue by Type (2027-2032) & (K Units) Table 28. Global VLP Vaccines Revenue Market Share by Type (2021-2026) Table 29. Global VLP Vaccines Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Government Table 31. Major Manufacturers of Medical Institution Table 32. Major Manufacturers of Others Table 33. Global VLP Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 35. Global VLP Vaccines Sales by Application (2027-2032) & (K Units) Table 36. Global VLP Vaccines Sales Market Share by Application (2021-2026) Table 37. Global VLP Vaccines Sales Market Share by Application (2027-2032) Table 38. Global VLP Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global VLP Vaccines Revenue by Application (2021-2026) & (K Units) Table 40. Global VLP Vaccines Revenue by Application (2027-2032) & (K Units) Table 41. Global VLP Vaccines Revenue Market Share by Application (2021-2026) Table 42. Global VLP Vaccines Revenue Market Share by Application (2027-2032) Table 43. Global VLP Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global VLP Vaccines Sales by Region (2021-2026) & (K Units) Table 45. Global VLP Vaccines Sales Market Share by Region (2021-2026) Table 46. Global VLP Vaccines Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global VLP Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 48. North America VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 50. North America VLP Vaccines Sales by Country (2027-2032) & (K Units) Table 51. Europe VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 53. Europe VLP Vaccines Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific VLP Vaccines Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa VLP Vaccines Sales by Country (2027-2032) & (K Units) Table 60. Global VLP Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global VLP Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 62. Global VLP Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 63. Global VLP Vaccines Revenue Market Share by Region (2021-2026) Table 64. Global VLP Vaccines Revenue Market Share by Region (2027-2032) Table 65. H&Z Life Science Company Information Table 66. H&Z Life Science Business Overview Table 67. H&Z Life Science VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. H&Z Life Science VLP Vaccines Product Portfolio Table 69. H&Z Life Science Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck VLP Vaccines Product Portfolio Table 74. Merck Recent Development Table 75. Gproan Company Information Table 76. Gproan Business Overview Table 77. Gproan VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Gproan VLP Vaccines Product Portfolio Table 79. Gproan Recent Development Table 80. VLP Therapeutics Company Information Table 81. VLP Therapeutics Business Overview Table 82. VLP Therapeutics VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. VLP Therapeutics VLP Vaccines Product Portfolio Table 84. VLP Therapeutics Recent Development Table 85. VBI Company Information Table 86. VBI Business Overview Table 87. VBI VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. VBI VLP Vaccines Product Portfolio Table 89. VBI Recent Development Table 90. Spybiotech Company Information Table 91. Spybiotech Business Overview Table 92. Spybiotech VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Spybiotech VLP Vaccines Product Portfolio Table 94. Spybiotech Recent Development Table 95. Saiba Animal Health Company Information Table 96. Saiba Animal Health Business Overview Table 97. Saiba Animal Health VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Saiba Animal Health VLP Vaccines Product Portfolio Table 99. Saiba Animal Health Recent Development Table 100. POSVAX Company Information Table 101. POSVAX Business Overview Table 102. POSVAX VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. POSVAX VLP Vaccines Product Portfolio Table 104. POSVAX Recent Development Table 105. Optipharm Co. Ltd Company Information Table 106. Optipharm Co. Ltd Business Overview Table 107. Optipharm Co. Ltd VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Optipharm Co. Ltd VLP Vaccines Product Portfolio Table 109. Optipharm Co. Ltd Recent Development Table 110. Novavax Company Information Table 111. Novavax Business Overview Table 112. Novavax VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Novavax VLP Vaccines Product Portfolio Table 114. Novavax Recent Development Table 115. Medicago Company Information Table 116. Medicago Business Overview Table 117. Medicago VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Medicago VLP Vaccines Product Portfolio Table 119. Medicago Recent Development Table 120. ARTES Biotechnology Company Information Table 121. ARTES Biotechnology Business Overview Table 122. ARTES Biotechnology VLP Vaccines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. ARTES Biotechnology VLP Vaccines Product Portfolio Table 124. ARTES Biotechnology Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. VLP Vaccines Distributors List Table 128. VLP Vaccines Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. VLP Vaccines Product Image Figure 2. Global VLP Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global VLP Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global VLP Vaccines Sales (2021-2032) & (K Units) Figure 5. Global VLP Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 VLP Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hepatitis B Vaccine Image Figure 9. Covid-19 Vaccine Image Figure 10. HPV Vaccine Image Figure 11. Others Image Figure 12. Global VLP Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global VLP Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global VLP Vaccines Sales Market Share by Type (2021-2032) Figure 15. Global VLP Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global VLP Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global VLP Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Government Image Figure 19. Medical Institution Image Figure 20. Others Image Figure 21. Global VLP Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global VLP Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global VLP Vaccines Sales Market Share by Application (2021-2032) Figure 24. Global VLP Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global VLP Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global VLP Vaccines Revenue Market Share by Application (2021-2032) Figure 27. North America VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America VLP Vaccines Sales Market Share by Country (2021-2032) Figure 29. U.S. VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe VLP Vaccines Sales Market Share by Country (2021-2032) Figure 34. Germany VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific VLP Vaccines Sales Market Share by Country (2021-2032) Figure 41. China VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa VLP Vaccines Sales Market Share by Country (2021-2032) Figure 49. Brazil VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile VLP Vaccines Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global VLP Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global VLP Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America VLP Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. North America VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe VLP Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Europe VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific VLP Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa VLP Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. VLP Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. VLP Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Vaccine
  • Covid-19 Vaccine
  • HPV Vaccine
  • Others
Applications
  • Government
  • Medical Institution
  • Others
Companies covered
  • H&Z Life Science
  • Merck
  • Gproan
  • VLP Therapeutics
  • VBI
  • Spybiotech
  • Saiba Animal Health
  • POSVAX
  • Optipharm Co. Ltd
  • Novavax
  • Medicago
  • ARTES Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global VLP Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global VLP Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global VLP Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global VLP Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global VLP Vaccines Market Dynamics
  1. 2.1 VLP Vaccines Industry Trends
  2. 2.2 VLP Vaccines Industry Drivers
  3. 2.3 VLP Vaccines Industry Opportunities and Challenges
  4. 2.4 VLP Vaccines Industry Restraints
3 VLP Vaccines Market by Manufacturers
  1. 3.1 Global VLP Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global VLP Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global VLP Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global VLP Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global VLP Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global VLP Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global VLP Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global VLP Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 VLP Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 VLP Vaccines Tier 1, Tier 2, and Tier 3
4 VLP Vaccines Market by Type
  1. 4.1 VLP Vaccines Type Introduction
  2. 4.1.1 Hepatitis B Vaccine
  3. 4.1.2 Covid-19 Vaccine
  4. 4.1.3 HPV Vaccine
  5. 4.1.4 Others
  6. 4.2 Global VLP Vaccines Sales by Type
  7. 4.2.1 Global VLP Vaccines Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global VLP Vaccines Sales by Type (2021-2032)
  9. 4.2.3 Global VLP Vaccines Sales Market Share by Type (2021-2032)
  10. 4.3 Global VLP Vaccines Revenue by Type
  11. 4.3.1 Global VLP Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global VLP Vaccines Revenue by Type (2021-2032)
  13. 4.3.3 Global VLP Vaccines Revenue Market Share by Type (2021-2032)
5 VLP Vaccines Market by Application
  1. 5.1 VLP Vaccines Application Introduction
  2. 5.1.1 Government
  3. 5.1.2 Medical Institution
  4. 5.1.3 Others
  5. 5.2 Global VLP Vaccines Sales by Application
  6. 5.2.1 Global VLP Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global VLP Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global VLP Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global VLP Vaccines Revenue by Application
  10. 5.3.1 Global VLP Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global VLP Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global VLP Vaccines Revenue Market Share by Application (2021-2032)
6 Global VLP Vaccines Sales by Region
  1. 6.1 Global VLP Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global VLP Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global VLP Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global VLP Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America VLP Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe VLP Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific VLP Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa VLP Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa VLP Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global VLP Vaccines Revenue by Region
  1. 7.1 Global VLP Vaccines Revenue by Region
  2. 7.1.1 Global VLP Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global VLP Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global VLP Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global VLP Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America VLP Vaccines Revenue (2021-2032)
  8. 7.2.2 North America VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe VLP Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific VLP Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa VLP Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa VLP Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 H&Z Life Science
  2. 8.1.1 H&Z Life Science Company Information
  3. 8.1.2 H&Z Life Science Business Overview
  4. 8.1.3 H&Z Life Science VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 H&Z Life Science VLP Vaccines Product Portfolio
  6. 8.1.5 H&Z Life Science Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck VLP Vaccines Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Gproan
  14. 8.3.1 Gproan Company Information
  15. 8.3.2 Gproan Business Overview
  16. 8.3.3 Gproan VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gproan VLP Vaccines Product Portfolio
  18. 8.3.5 Gproan Recent Developments
  19. 8.4 VLP Therapeutics
  20. 8.4.1 VLP Therapeutics Company Information
  21. 8.4.2 VLP Therapeutics Business Overview
  22. 8.4.3 VLP Therapeutics VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 VLP Therapeutics VLP Vaccines Product Portfolio
  24. 8.4.5 VLP Therapeutics Recent Developments
  25. 8.5 VBI
  26. 8.5.1 VBI Company Information
  27. 8.5.2 VBI Business Overview
  28. 8.5.3 VBI VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 VBI VLP Vaccines Product Portfolio
  30. 8.5.5 VBI Recent Developments
  31. 8.6 Spybiotech
  32. 8.6.1 Spybiotech Company Information
  33. 8.6.2 Spybiotech Business Overview
  34. 8.6.3 Spybiotech VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Spybiotech VLP Vaccines Product Portfolio
  36. 8.6.5 Spybiotech Recent Developments
  37. 8.7 Saiba Animal Health
  38. 8.7.1 Saiba Animal Health Company Information
  39. 8.7.2 Saiba Animal Health Business Overview
  40. 8.7.3 Saiba Animal Health VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Saiba Animal Health VLP Vaccines Product Portfolio
  42. 8.7.5 Saiba Animal Health Recent Developments
  43. 8.8 POSVAX
  44. 8.8.1 POSVAX Company Information
  45. 8.8.2 POSVAX Business Overview
  46. 8.8.3 POSVAX VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 POSVAX VLP Vaccines Product Portfolio
  48. 8.8.5 POSVAX Recent Developments
  49. 8.9 Optipharm Co. Ltd
  50. 8.9.1 Optipharm Co. Ltd Company Information
  51. 8.9.2 Optipharm Co. Ltd Business Overview
  52. 8.9.3 Optipharm Co. Ltd VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Optipharm Co. Ltd VLP Vaccines Product Portfolio
  54. 8.9.5 Optipharm Co. Ltd Recent Developments
  55. 8.10 Novavax
  56. 8.10.1 Novavax Company Information
  57. 8.10.2 Novavax Business Overview
  58. 8.10.3 Novavax VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novavax VLP Vaccines Product Portfolio
  60. 8.10.5 Novavax Recent Developments
  61. 8.11 Medicago
  62. 8.11.1 Medicago Company Information
  63. 8.11.2 Medicago Business Overview
  64. 8.11.3 Medicago VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medicago VLP Vaccines Product Portfolio
  66. 8.11.5 Medicago Recent Developments
  67. 8.12 ARTES Biotechnology
  68. 8.12.1 ARTES Biotechnology Company Information
  69. 8.12.2 ARTES Biotechnology Business Overview
  70. 8.12.3 ARTES Biotechnology VLP Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ARTES Biotechnology VLP Vaccines Product Portfolio
  72. 8.12.5 ARTES Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 VLP Vaccines Value Chain Analysis
  2. 9.1.1 VLP Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 VLP Vaccines Production Mode & Process
  6. 9.2 VLP Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 VLP Vaccines Distributors
  9. 9.2.3 VLP Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst